main

Guidelines for Inspection

Guidelines for GMP

Guidelines for GLP

Guidelines for GSP

About APSO
Benefits of APSO
Latest News
Contact us
Guidelines
Recorded Companies
Awarded Companies
Services
Drug Information Center
Links
Experts
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CHAPTER 01

REF:

WHO 32

ADMINISTRATION AND GENERAL INFORMATION

1

What is the company's name?

________________________________________________

 

2

What is the company's legal address?

___________________________________________________________

___________________________________________________________

 

3

What is the manufacturing site’s address?

___________________________________________________________

___________________________________________________________

 

4

Does the company have authorization, according to the regulations of each country, at other address(es) (warehouses, quality control laboratory, etc.) which are under the company’s responsibility?

 If "YES", indicate which companies and provide their addresses.

___________________________________________________________

___________________________________________________________

___________________________________________________________

 

5

Is there evidence of registration of the qualified person responsible by the Regulatory Authority?

___________________________________________________________

___________________________________________________________

 

6

Is the qualified person responsible, according to company's organization chart, present at the time of the inspection?

YES

PROVIDE INFORMATION REGARDING THIS PERSON (WHO RECEIVES THE INSPECTION)

-------------------------------------------------------------------------------------------------------

NO

 

   

REF:

WHO 32

ADMINISTRATION AND GENERAL INFORMATION

7

Is there evidence of a license to operate issued by the Regulatory Authority?

Indicate all authorized activities

___________________________________________________________

___________________________________________________________

___________________________________________________________

8

Does the company develop exclusively those production and quality control activities properly authorized by the Regulatory Authority?

 YES

NO

9

Does the company manufacture dietary supplements?

 YES

NO

10

Does the company manufacture cosmetic products?

 YES

NO

 

11

Does the company manufacture veterinary products?

 YES

NO

 

12

Does the company manufacture reagents for “in vitro” diagnostic use?

 YES

NO

 

13

Does the company manufacture reagents for “in vivo” diagnostic use?

 YES

NO

 

14

Does the company manufacture other products not indicated above?

 YES

If “YES” indicate below

-----------------------------------------------------------------------------------------------------

NO

REF:

WHO 32

ADMINISTRATION AND GENERAL INFORMATION

15

Does the company manufacture products with beta-lactam active ingredients (penicillins / cephalosporins)?

YES

If "YES", indicate in which pharmaceutical dosage form

-----------------------------------------------------------------------------------------------

NO

 

16

Does the company manufacture products with cytostatic / cytotoxic active ingredients?

YES

 If "YES", indicate in which pharmaceutical dosage form

---------------------------------------------------------------------------------------------------------

NO

17

Does the company manufacture products with hormone active ingredients?

 YES

 If "YES", indicate in which pharmaceutical dosage form

-----------------------------------------------------------------------------------------------------------------------

NO

 

17.1

Does the company manufacture products with corticosteroids active ingredients?

 YES

 If "YES", indicate in which pharmaceutical dosage form

----------------------------------------------------------------------------------------

NO

18

Does the company manufacture products with active ingredients from biological origin?

 YES

 If "YES", indicate in which pharmaceutical dosage form

-----------------------------------------------------------------

NO

 

REF:

WHO 32

ADMINISTRATION AND GENERAL INFORMATION

19

Does the company manufacture products with active ingredients from biotechnological origin?

 YES

 If "YES", indicate in which pharmaceutical dosage form

----------------------------------------------------------------

NO

 

20

Is there a list available of current licensed products? Attach the list

 YES

NO

 

21

Is there a list available of marketed products? Attach the list

 YES

NO

 

21.1

Do all marketed products and its pharmaceutical presentations have current (valid) license?

 YES

NO

 

22

Are the updated building schematics approved by the Regulatory Authority shown, if required?

 YES

NO

23

Section 8.

 

Does the company have contract production activities?

 YES

NO

24

Section 8

 

Is there documentation certifying registration /authorization of the third party contracted by the Regulatory Authority?

 YES

NO

 

 

REF:

WHO 32

ADMINISTRATION AND GENERAL INFORMATION

25

Section 8.15

 

Is there batch documentation issued by the third party in charge of production?

 

YES

NO

26

Section 8

Does the company act as a third party producer?

 

YES

NO

27

Sections 8.1,

8.3, 8.12 and

8.13

 

If the company produces by or for third parties, are there contracts that link the parties?

 

YES

NO

 

  Go to Chapter 02

Download Chapter 01